Survey of Clinical Practice for Irritable Bowel Syndrome in East Asian Countries
Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypot...
Saved in:
Published in | Digestion Vol. 91; no. 1; pp. 99 - 109 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
S. Karger AG
01.01.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Subjects and Methods: Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Results: Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. Conclusion: This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries. |
---|---|
AbstractList | Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries.AIMSociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries.Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS.SUBJECTS AND METHODSStudy participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS.Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists.RESULTSSubjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists.This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries.CONCLUSIONThis survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries. Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Subjects and Methods: Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Results: Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. Conclusion: This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries. Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries. Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues towards solving this problem. The aims of this study were to depict the clinical realities of IBS in East Asian countries and test the hypothesis that the diagnosis and treatment of IBS differ between countries. Subjects and Methods: Study participants were 251 physicians involved in the clinical practice of IBS at major institutions in Japan, South Korea, China, the Philippines, Indonesia and Singapore. The questionnaire contained 45 questions focused on the clinical practice of IBS. Results: Subjects in Japan, South Korea, China, Indonesia, the Philippines and Singapore accounted for 55.4, 17.9, 8.8, 8.0, 6.4 and 3.6% of the study cohort, respectively. Amongst East Asian physicians, the most important symptom was considered to be abdominal pain by 33.4%, whilst 24.3% regarded alternating diarrhea and constipation to be the most important symptoms. Total colonoscopy and histopathology use showed no difference among countries. Prescriptions given for mild (p < 0.0001), moderate (p < 0.0001), severe (p < 0.0001), intractable (p = 0.002), diarrheal (p < 0.0001) and constipating (p < 0.0001) patients with IBS significantly differed between the countries. Except for several minor points, IBS specialists showed no significant difference in their diagnosis and treatment of IBS when compared to nonspecialists. Conclusion: This survey provided data on the clinical treatment of IBS among East Asian countries. The results supported the hypothesis that the diagnosis and treatment of IBS differs between countries. © 2015 S. Karger AG, Basel |
Author | Takahashi, Shin'ichi Kinoshita, Yoshikazu Rani, Abdul A. Ueno, Fumiaki Hahm, Ki-Baik Fukudo, Shin Suzuki, Hidekazu Sollano, Jose D. Uchiyama, Kazuhiko Kamiya, Takeshi Naito, Yuji Syam, Ari F. Yamagami, Hirokazu Fock, Kwong M. Zhu, Qi Arakawa, Tetsuo Kachintorn, Udom Joh, Takashi Chan, Francis K.L. |
Author_xml | – sequence: 1 givenname: Shin surname: Fukudo fullname: Fukudo, Shin email: sfukudo@med.tohoku.ac.jp – sequence: 2 givenname: Ki-Baik surname: Hahm fullname: Hahm, Ki-Baik – sequence: 3 givenname: Qi surname: Zhu fullname: Zhu, Qi – sequence: 4 givenname: Jose D. surname: Sollano fullname: Sollano, Jose D. – sequence: 5 givenname: Abdul A. surname: Rani fullname: Rani, Abdul A. – sequence: 6 givenname: Ari F. surname: Syam fullname: Syam, Ari F. – sequence: 7 givenname: Udom surname: Kachintorn fullname: Kachintorn, Udom – sequence: 8 givenname: Hidekazu surname: Suzuki fullname: Suzuki, Hidekazu – sequence: 9 givenname: Takeshi surname: Kamiya fullname: Kamiya, Takeshi – sequence: 10 givenname: Takashi surname: Joh fullname: Joh, Takashi – sequence: 11 givenname: Kazuhiko surname: Uchiyama fullname: Uchiyama, Kazuhiko – sequence: 12 givenname: Yuji surname: Naito fullname: Naito, Yuji – sequence: 13 givenname: Shin'ichi surname: Takahashi fullname: Takahashi, Shin'ichi – sequence: 14 givenname: Yoshikazu surname: Kinoshita fullname: Kinoshita, Yoshikazu – sequence: 15 givenname: Fumiaki surname: Ueno fullname: Ueno, Fumiaki – sequence: 16 givenname: Hirokazu surname: Yamagami fullname: Yamagami, Hirokazu – sequence: 17 givenname: Francis K.L. surname: Chan fullname: Chan, Francis K.L. – sequence: 18 givenname: Kwong M. surname: Fock fullname: Fock, Kwong M. – sequence: 19 givenname: Tetsuo surname: Arakawa fullname: Arakawa, Tetsuo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25632923$$D View this record in MEDLINE/PubMed |
BookMark | eNpt0UtPGzEQAGC3TQWB5tA7Qpa4lMMWP9f2ESJeElKR0p5XtndSmW5ssHdb5d-zKAkSqKeRNd-MxjMHaBJTBIS-UvKdUmnOCCG8NkTpD2hmlOacasIJ1fQjmlLBaGV0rT69ySkxQVNCKKuYZnwfHZTy8PI0gu-hfSZrzgzjU3S_GPJfWOO0xPMuxOBth--z9X3wgJcp49ucQ29dB_gi_YMOL9axzWkFOER8aUuPz0uwEc_TEPscoHxBn5e2KzDbxkP06-ry5_ymuvtxfTs_v6s8r2VfUesEpdobCq5tbauVNK0mlnurpHWetx5qKZ3ixgFzWhAnhVeEKUUlaOCH6Num72NOTwOUvlmF4qHrbIQ0lIbWkgmhieEjPXlHH9KQ4zjdRtVSCTOq460a3Ara5jGHlc3rZrerEZxtgM-plAzLxo-b6UMaP25D11DSvFyreb3WWHH6rmLX9H_2aGP_2Pwb8qvcpp8BSHmVjg |
CODEN | DIGEBW |
CitedBy_id | crossref_primary_10_1111_nmo_14581 crossref_primary_10_1007_s00535_016_1165_5 crossref_primary_10_1111_nmo_13131 crossref_primary_10_1097_SGA_0000000000000330 crossref_primary_10_1111_nmo_13023 crossref_primary_10_3390_nu14102015 crossref_primary_10_5056_jnm22037 crossref_primary_10_5217_ir_2017_15_2_236 crossref_primary_10_1111_nmo_13402 crossref_primary_10_1002_jgh3_12665 crossref_primary_10_1053_j_gastro_2020_04_014 crossref_primary_10_1111_apt_16467 crossref_primary_10_1371_journal_pone_0129345 crossref_primary_10_1177_2156587216628374 |
Cites_doi | 10.1053/j.gastro.2006.03.008 10.1053/j.gastro.2005.11.061 10.1053/j.gastro.2004.03.012 10.1038/ajg.2009.341 10.1111/j.1440-1746.2006.04136.x 10.1111/j.1365-2036.2009.04087.x 10.1371/journal.pone.0054183 10.1111/j.1365-2036.2004.02128.x 10.1111/j.1440-1746.2010.06338.x 10.1007/s00535-009-0168-x 10.1053/gast.2000.16484 10.1002/ibd.20059 10.1002/14651858.CD003460.pub3 10.1038/ajgsup.2014.6 10.1038/ajg.2009.621 10.1038/nature08937 10.1111/j.1365-2036.2005.02463.x 10.1016/j.cgh.2014.08.026 10.1038/ajg.2010.58 10.1111/j.1365-2982.2011.01668.x 10.1136/gut.42.3.414 10.1136/gut.2008.167270 10.1016/j.cgh.2013.11.024 10.1111/nmo.12402 10.1111/j.1365-2036.2011.04715.x 10.1111/j.1572-0241.2002.07027.x 10.1016/S0002-9270(03)00705-6 10.1111/apt.12938 10.1111/j.1365-2982.2011.01732.x 10.1016/j.cgh.2012.02.029 10.1111/j.1365-2036.2006.02938.x 10.1097/MCG.0b013e318150d006 10.1111/j.1440-1746.2010.06353.x 10.1001/archinternmed.2009.22 10.1111/j.0269-2813.2004.01862.x 10.1002/14651858.CD006442.pub2 10.1111/apt.12942 10.1111/j.1440-1746.2011.06635.x 10.1053/j.gastro.2005.09.071 |
ContentType | Journal Article |
Copyright | 2015 S. Karger AG, Basel 2015 S. Karger AG, Basel. Copyright (c) 2015 S. Karger AG, Basel |
Copyright_xml | – notice: 2015 S. Karger AG, Basel – notice: 2015 S. Karger AG, Basel. – notice: Copyright (c) 2015 S. Karger AG, Basel |
CorporateAuthor | The International Gastrointestinal Consensus Symposium Study Group International Gastrointestinal Consensus Symposium Study Group |
CorporateAuthor_xml | – name: The International Gastrointestinal Consensus Symposium Study Group – name: International Gastrointestinal Consensus Symposium Study Group |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS S0X 7X8 |
DOI | 10.1159/000369078 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China SIRS Editorial MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) SIRS Editorial ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic CrossRef MEDLINE ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISBN | 9783318030181 331803018X |
EISSN | 1421-9867 |
EndPage | 109 |
ExternalDocumentID | 3584140081 25632923 10_1159_000369078 369078 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Singapore Asia China Japan Philippines Republic of Korea Indonesia |
GeographicLocations_xml | – name: Singapore – name: Republic of Korea – name: Asia – name: Philippines – name: Japan – name: China – name: Indonesia |
GroupedDBID | --- .55 .GJ 0R~ 0~5 0~B 29G 30W 327 34G 36B 39C 3O. 3V. 4.4 53G 5GY 5RE 7X7 88E 8AO 8FI 8FJ 8UI AAYIC AAYJJ ABJNI ABPAZ ABUWG ACGFS ACPRK ACPSR ADAGL ADBBV AENEX AEYAO AFFNX AFJJK AFKRA AFOSN AHMBA AI. ALDHI ALIPV ALMA_UNASSIGNED_HOLDINGS APPQY AZPMC BENPR BPHCQ BVXVI CAG CCPQU COF CS3 CYUIP DU5 E0A EBS EJD EMB EMOBN F5P FB. FYUFA HMCUK HZ~ IY7 KUZGX L7B M1P N9A O1H O9- PQQKQ PROAC PSQYO RIG RKO RXVBD S0X SV3 UJ6 UKHRP VH1 X7M ZGI ZXP AAYXX ABBTS ABWCG ACQXL AFSIO AHFRZ CITATION PHGZM PHGZT PJZUB PPXIY CGR CUY CVF ECM EIF NPM 7QP 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c365t-1ab4118c91ebddad8759d80a3ca75abc3dce655b739be2b840b54c7027715e8e3 |
IEDL.DBID | 7X7 |
ISBN | 9783318030174 3318030171 |
ISSN | 0012-2823 1421-9867 |
IngestDate | Thu Jul 10 19:16:14 EDT 2025 Sat Aug 23 12:29:37 EDT 2025 Mon Jul 21 06:05:00 EDT 2025 Thu Apr 24 23:01:16 EDT 2025 Tue Aug 05 11:59:34 EDT 2025 Thu Aug 29 12:04:39 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Functional gastrointestinal disorders East Asian countries Irritable bowel syndrome Rome III criteria |
Language | English |
License | Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. https://www.karger.com/Services/SiteLicenses 2015 S. Karger AG, Basel. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c365t-1ab4118c91ebddad8759d80a3ca75abc3dce655b739be2b840b54c7027715e8e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.karger.com/Article/Pdf/369078 |
PMID | 25632923 |
PQID | 1652465749 |
PQPubID | 2207 |
PageCount | 11 |
ParticipantIDs | proquest_miscellaneous_1652448093 karger_primary_369078 pubmed_primary_25632923 proquest_journals_1652465749 crossref_citationtrail_10_1159_000369078 crossref_primary_10_1159_000369078 |
PublicationCentury | 2000 |
PublicationDate | 20150100 2015-00-00 20150101 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – month: 01 year: 2015 text: 20150100 |
PublicationDecade | 2010 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Switzerland – name: Basel |
PublicationTitle | Digestion |
PublicationTitleAlternate | Digestion |
PublicationYear | 2015 |
Publisher | S. Karger AG |
Publisher_xml | – name: S. Karger AG |
References | Güçlü M, Pourbagher A, Serin E, et al: Ultrasonographic evaluation of gallbladder functions in patients with irritable bowel syndrome. J Gastroenterol Hepatol 2006;21:1309-1312.1687231510.1111/j.1440-1746.2006.04136.x Kim ES, Cheon JH, Park JJ, Moon CM, Hong SP, Kim TI, Kim WH: Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception. J Gastroenterol Hepatol 2010;25:1232-1238.2059424910.1111/j.1440-1746.2010.06338.x Tack J: Systematic review: the efficacy of treatments for irritable bowel syndrome: a European perspective. Aliment Pharmacol Ther 2006;24:183-205.1684244810.1111/j.1365-2036.2006.02938.x Cash BD, Schoenfeld P, Chey WD: The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002;97:S7-S261242555310.1111/j.1572-0241.2002.07027.x Shinozaki M, Fukudo S, Hongo M, Shimosegawa T, Sasaki D, Matsueda K, Harasawa S, Miura S, Mine T, Kaneko H, Arakawa T, Haruma K, Torii A, Azuma T, Miwa H, Fukunaga M, Handa M, Kitamori S, Miwa T, et al: High prevalence of irritable bowel syndrome in medical outpatients in Japan. J Clin Gastroenterol 2008;42:1010-1016.1860729510.1097/MCG.0b013e318150d006 Moayyedi P, Ford AC, Talley NJ, et al: The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010;59:325-332.1909182310.1136/gut.2008.167270 Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003;98:2454-2459.1463834810.1016/S0002-9270(03)00705-6 Drossman D, Szigethy E: The narcotic bowel syndrome: a recent update. Am J Gastroenterol 2014;2:22-30.2520760910.1038/ajgsup.2014.6 Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V: Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005;21:1365-1375.1593236710.1111/j.1365-2036.2005.02463.x Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology 2006;130:1480-1491.1667856110.1053/j.gastro.2005.11.061 Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB: Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther 2004;20:615-621.1535290910.1111/j.1365-2036.2004.02128.x Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW: Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011;8:CD003460.2183394510.1002/14651858.CD003460.pub3 Okumura T, Tanno S, Ohhira M, Tanno S: Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol 2010;45:187-194.1999785410.1007/s00535-009-0168-x Drossman DA: Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms. Am J Gastroenterol 2009;104:2897-29021995611510.1038/ajg.2009.341 Jellema P, van der Windt DA, Schellevis FG, et al: Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther 2009;30:695-706.1957576310.1111/j.1365-2036.2009.04087.x Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.1667855310.1053/j.gastro.2006.03.008 Sperber AD, Gwee KA, Hungin AP, Corazziari E, Fukudo S, Gerson C, Ghoshal UC, Kang JY, Levy RL, Schmulson M, Dumitrascu D, Gerson MJ, Chen M, Myung SJ, Quigley EM, Whorwell PJ, Zarzar K, Whitehead WE: Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations: a Rome Foundation working team report. Aliment Pharmacol Ther 2014;40:1094-1102.2517599810.1111/apt.12942 Bijkerk CJ, Muris JW, Knottnerus JA, et al: Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004;19:245-251.1498437010.1111/j.0269-2813.2004.01862.x Schmulson M, Corazziari E, Ghoshal UC, Myung SJ, Gerson CD, Quigley EM, Gwee KA, Sperber AD: A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome Foundation Working Team on cross-cultural, multinational research. Neurogastroenterol Motil 2014;26:1368-1385.2508745110.1111/nmo.12402 Fukudo S, Hongo M, Kaneko H, Takano M, Ueno R: Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol 2014, Epub ahead of print.2515892510.1016/j.cgh.2014.08.026 Fukudo S, Hongo M, Kaneko H, Ueno R: Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study. Neurogastroenterol Motil 2011;23:544-e205.2130343010.1111/j.1365-2982.2011.01668.x Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE: Functional gastrointestinal disorders: psychological, social, and somatic features. Gut 1998;42:414-420.957735110.1136/gut.42.3.414 Dong YY, Chen FX, Yu YB, Du C, Qi QQ, Liu H, Li YQ: A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students. PLoS One 2013;8:e54183.2334982010.1371/journal.pone.0054183 Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, Sperber AD: Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006;130:1435-1446.1667855710.1053/j.gastro.2005.09.071 Spiegel BM, DeRosa VP, Gralnek IM, et al: Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 2004;126:1721-1732.1518816710.1053/j.gastro.2004.03.012 Limsui D, Pardi DS, Camilleri M, et al: Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007;13:175-181.1720669910.1002/ibd.20059 Miura S, Sugano K, Kinoshita Y, Fock KM, Goh KL, Gibson P, et al: Diagnosis and treatment of functional gastrointestinal disorders in the Asia-Pacific region: a survey of current practices. J Gastroenterol Hepatol 2011;26(suppl 3):2-11.2144369910.1111/j.1440-1746.2011.06635.x Canavan C, West J, Card T: Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014;40:1023-1034.2519990410.1111/apt.12938 Hanevik K, Dizdar V, Langeland N, et al: Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome. Aliment Pharmacol Ther 2011;34:259-260.2167921110.1111/j.1365-2036.2011.04715.x Kanazawa M, Watanabe S, Tana C, Komuro H, Aoki M, Fukudo S: Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome. Neurogastroenterol Motil 2011;23:754-e332.2161562310.1111/j.1365-2982.2011.01732.x Lovell RM, Ford AC: Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712-721.2242608710.1016/j.cgh.2012.02.029 Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA: The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-660.1098275810.1053/gast.2000.16484 Ford AC, Chey WD, Talley NJ, et al: Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009;169:651-658.1936499410.1001/archinternmed.2009.22 Zijdenbos IL, de Wit NJ, van der Heijden GJ, et al: Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009;1:CD006442.1916028610.1002/14651858.CD006442.pub2 Hehemann JH, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G: Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010;464:908-912.2037615010.1038/nature08937 Jung HK, Choung RS, Locke GR 3rd, et al: Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol 2010;105:652-661.1986195510.1038/ajg.2009.621 Fukudo S, Ida M, Akiho H, Nakashima Y, Matsueda K: Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2014;12:953-959.e4.2431588210.1016/j.cgh.2013.11.024 Schmulson M, Adeyemo M, Gutiérrez-Reyes G, Charúa-Guindic L, Farfán-Labonne B, Ostrosky-Solis F, Díaz-Anzaldúa A, Medina L, Chang L: Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Gastroenterol 2010;105:925-932.2017969310.1038/ajg.2010.58 Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, Chua AS, Lu CL, Goh KL, Kositchaiwat C, Makharia G, Park HJ, Chang FY, Fukudo S, Choi MG, Bhatia S, Ke M, Hou X, Hongo M, Asian Neurogastroenterology and Motility Association: Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1189-1205.2059424510.1111/j.1440-1746.2010.06353.x ref13 ref35 ref12 ref34 ref15 ref37 ref14 ref36 ref31 ref30 ref11 ref33 ref10 ref32 ref2 ref1 ref17 ref39 ref16 ref38 ref19 ref18 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref28 ref27 ref29 ref8 ref7 ref9 ref4 ref3 ref6 ref5 |
References_xml | – reference: Ford AC, Chey WD, Talley NJ, et al: Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med 2009;169:651-658.1936499410.1001/archinternmed.2009.22 – reference: Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW: Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011;8:CD003460.2183394510.1002/14651858.CD003460.pub3 – reference: Kanazawa M, Watanabe S, Tana C, Komuro H, Aoki M, Fukudo S: Effect of 5-HT4 receptor agonist mosapride citrate on rectosigmoid sensorimotor function in patients with irritable bowel syndrome. Neurogastroenterol Motil 2011;23:754-e332.2161562310.1111/j.1365-2982.2011.01732.x – reference: Sperber AD, Gwee KA, Hungin AP, Corazziari E, Fukudo S, Gerson C, Ghoshal UC, Kang JY, Levy RL, Schmulson M, Dumitrascu D, Gerson MJ, Chen M, Myung SJ, Quigley EM, Whorwell PJ, Zarzar K, Whitehead WE: Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations: a Rome Foundation working team report. Aliment Pharmacol Ther 2014;40:1094-1102.2517599810.1111/apt.12942 – reference: Tack J: Systematic review: the efficacy of treatments for irritable bowel syndrome: a European perspective. Aliment Pharmacol Ther 2006;24:183-205.1684244810.1111/j.1365-2036.2006.02938.x – reference: Bennett EJ, Piesse C, Palmer K, Badcock CA, Tennant CC, Kellow JE: Functional gastrointestinal disorders: psychological, social, and somatic features. Gut 1998;42:414-420.957735110.1136/gut.42.3.414 – reference: Bijkerk CJ, Muris JW, Knottnerus JA, et al: Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2004;19:245-251.1498437010.1111/j.0269-2813.2004.01862.x – reference: Miura S, Sugano K, Kinoshita Y, Fock KM, Goh KL, Gibson P, et al: Diagnosis and treatment of functional gastrointestinal disorders in the Asia-Pacific region: a survey of current practices. J Gastroenterol Hepatol 2011;26(suppl 3):2-11.2144369910.1111/j.1440-1746.2011.06635.x – reference: Okumura T, Tanno S, Ohhira M, Tanno S: Prevalence of functional dyspepsia in an outpatient clinic with primary care physicians in Japan. J Gastroenterol 2010;45:187-194.1999785410.1007/s00535-009-0168-x – reference: Dolwani S, Metzner M, Wassell JJ, Yong A, Hawthorne AB: Diagnostic accuracy of faecal calprotectin estimation in prediction of abnormal small bowel radiology. Aliment Pharmacol Ther 2004;20:615-621.1535290910.1111/j.1365-2036.2004.02128.x – reference: Jung HK, Choung RS, Locke GR 3rd, et al: Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study. Am J Gastroenterol 2010;105:652-661.1986195510.1038/ajg.2009.621 – reference: Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA: The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000;119:654-660.1098275810.1053/gast.2000.16484 – reference: Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006;130:1377-1390.1667855310.1053/j.gastro.2006.03.008 – reference: Hehemann JH, Correc G, Barbeyron T, Helbert W, Czjzek M, Michel G: Transfer of carbohydrate-active enzymes from marine bacteria to Japanese gut microbiota. Nature 2010;464:908-912.2037615010.1038/nature08937 – reference: Dong YY, Chen FX, Yu YB, Du C, Qi QQ, Liu H, Li YQ: A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students. PLoS One 2013;8:e54183.2334982010.1371/journal.pone.0054183 – reference: Hanevik K, Dizdar V, Langeland N, et al: Tolerability and effect of mesalazine in postinfectious irritable bowel syndrome. Aliment Pharmacol Ther 2011;34:259-260.2167921110.1111/j.1365-2036.2011.04715.x – reference: Drossman D, Szigethy E: The narcotic bowel syndrome: a recent update. Am J Gastroenterol 2014;2:22-30.2520760910.1038/ajgsup.2014.6 – reference: Kim ES, Cheon JH, Park JJ, Moon CM, Hong SP, Kim TI, Kim WH: Colonoscopy as an adjunctive method for the diagnosis of irritable bowel syndrome: focus on pain perception. J Gastroenterol Hepatol 2010;25:1232-1238.2059424910.1111/j.1440-1746.2010.06338.x – reference: Hungin AP, Chang L, Locke GR, Dennis EH, Barghout V: Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact. Aliment Pharmacol Ther 2005;21:1365-1375.1593236710.1111/j.1365-2036.2005.02463.x – reference: Shinozaki M, Fukudo S, Hongo M, Shimosegawa T, Sasaki D, Matsueda K, Harasawa S, Miura S, Mine T, Kaneko H, Arakawa T, Haruma K, Torii A, Azuma T, Miwa H, Fukunaga M, Handa M, Kitamori S, Miwa T, et al: High prevalence of irritable bowel syndrome in medical outpatients in Japan. J Clin Gastroenterol 2008;42:1010-1016.1860729510.1097/MCG.0b013e318150d006 – reference: Güçlü M, Pourbagher A, Serin E, et al: Ultrasonographic evaluation of gallbladder functions in patients with irritable bowel syndrome. J Gastroenterol Hepatol 2006;21:1309-1312.1687231510.1111/j.1440-1746.2006.04136.x – reference: Fukudo S, Hongo M, Kaneko H, Takano M, Ueno R: Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol 2014, Epub ahead of print.2515892510.1016/j.cgh.2014.08.026 – reference: Fukudo S, Ida M, Akiho H, Nakashima Y, Matsueda K: Effect of ramosetron on stool consistency in male patients with irritable bowel syndrome with diarrhea. Clin Gastroenterol Hepatol 2014;12:953-959.e4.2431588210.1016/j.cgh.2013.11.024 – reference: Gwee KA, Bak YT, Ghoshal UC, Gonlachanvit S, Lee OY, Fock KM, Chua AS, Lu CL, Goh KL, Kositchaiwat C, Makharia G, Park HJ, Chang FY, Fukudo S, Choi MG, Bhatia S, Ke M, Hou X, Hongo M, Asian Neurogastroenterology and Motility Association: Asian consensus on irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1189-1205.2059424510.1111/j.1440-1746.2010.06353.x – reference: Drossman DA: Beyond tricyclics: new ideas for treating patients with painful and refractory functional gastrointestinal symptoms. Am J Gastroenterol 2009;104:2897-29021995611510.1038/ajg.2009.341 – reference: Moayyedi P, Ford AC, Talley NJ, et al: The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010;59:325-332.1909182310.1136/gut.2008.167270 – reference: Canavan C, West J, Card T: Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther 2014;40:1023-1034.2519990410.1111/apt.12938 – reference: Zijdenbos IL, de Wit NJ, van der Heijden GJ, et al: Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev 2009;1:CD006442.1916028610.1002/14651858.CD006442.pub2 – reference: Lovell RM, Ford AC: Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10:712-721.2242608710.1016/j.cgh.2012.02.029 – reference: Jellema P, van der Windt DA, Schellevis FG, et al: Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Aliment Pharmacol Ther 2009;30:695-706.1957576310.1111/j.1365-2036.2009.04087.x – reference: Schmulson M, Adeyemo M, Gutiérrez-Reyes G, Charúa-Guindic L, Farfán-Labonne B, Ostrosky-Solis F, Díaz-Anzaldúa A, Medina L, Chang L: Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population. Am J Gastroenterol 2010;105:925-932.2017969310.1038/ajg.2010.58 – reference: Spiegel BM, DeRosa VP, Gralnek IM, et al: Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis. Gastroenterology 2004;126:1721-1732.1518816710.1053/j.gastro.2004.03.012 – reference: Schmulson M, Corazziari E, Ghoshal UC, Myung SJ, Gerson CD, Quigley EM, Gwee KA, Sperber AD: A four-country comparison of healthcare systems, implementation of diagnostic criteria, and treatment availability for functional gastrointestinal disorders: a report of the Rome Foundation Working Team on cross-cultural, multinational research. Neurogastroenterol Motil 2014;26:1368-1385.2508745110.1111/nmo.12402 – reference: Fukudo S, Hongo M, Kaneko H, Ueno R: Efficacy and safety of oral lubiprostone in constipated patients with or without irritable bowel syndrome: a randomized, placebo-controlled and dose-finding study. Neurogastroenterol Motil 2011;23:544-e205.2130343010.1111/j.1365-2982.2011.01668.x – reference: Chang L, Toner BB, Fukudo S, Guthrie E, Locke GR, Norton NJ, Sperber AD: Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006;130:1435-1446.1667855710.1053/j.gastro.2005.09.071 – reference: Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD: Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol 2003;98:2454-2459.1463834810.1016/S0002-9270(03)00705-6 – reference: Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC: Functional bowel disorders. Gastroenterology 2006;130:1480-1491.1667856110.1053/j.gastro.2005.11.061 – reference: Cash BD, Schoenfeld P, Chey WD: The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review. Am J Gastroenterol 2002;97:S7-S261242555310.1111/j.1572-0241.2002.07027.x – reference: Limsui D, Pardi DS, Camilleri M, et al: Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007;13:175-181.1720669910.1002/ibd.20059 – ident: ref1 doi: 10.1053/j.gastro.2006.03.008 – ident: ref2 doi: 10.1053/j.gastro.2005.11.061 – ident: ref20 doi: 10.1053/j.gastro.2004.03.012 – ident: ref36 doi: 10.1038/ajg.2009.341 – ident: ref19 doi: 10.1111/j.1440-1746.2006.04136.x – ident: ref25 doi: 10.1111/j.1365-2036.2009.04087.x – ident: ref14 doi: 10.1371/journal.pone.0054183 – ident: ref16 doi: 10.1111/j.1365-2036.2004.02128.x – ident: ref17 doi: 10.1111/j.1440-1746.2010.06338.x – ident: ref11 doi: 10.1007/s00535-009-0168-x – ident: ref4 doi: 10.1053/gast.2000.16484 – ident: ref22 doi: 10.1002/ibd.20059 – ident: ref30 doi: 10.1002/14651858.CD003460.pub3 – ident: ref38 doi: 10.1038/ajgsup.2014.6 – ident: ref18 doi: 10.1038/ajg.2009.621 – ident: ref8 doi: 10.1038/nature08937 – ident: ref24 doi: 10.1111/j.1365-2036.2005.02463.x – ident: ref35 doi: 10.1016/j.cgh.2014.08.026 – ident: ref13 doi: 10.1038/ajg.2010.58 – ident: ref34 doi: 10.1111/j.1365-2982.2011.01668.x – ident: ref12 doi: 10.1136/gut.42.3.414 – ident: ref27 doi: 10.1136/gut.2008.167270 – ident: ref32 doi: 10.1016/j.cgh.2013.11.024 – ident: ref39 doi: 10.1111/nmo.12402 – ident: ref37 doi: 10.1111/j.1365-2036.2011.04715.x – ident: ref23 doi: 10.1111/j.1572-0241.2002.07027.x – ident: ref15 doi: 10.1016/S0002-9270(03)00705-6 – ident: ref5 doi: 10.1111/apt.12938 – ident: ref33 doi: 10.1111/j.1365-2982.2011.01732.x – ident: ref3 doi: 10.1016/j.cgh.2012.02.029 – ident: ref28 doi: 10.1111/j.1365-2036.2006.02938.x – ident: ref26 doi: 10.1097/MCG.0b013e318150d006 – ident: ref9 doi: 10.1111/j.1440-1746.2010.06353.x – ident: ref21 doi: 10.1001/archinternmed.2009.22 – ident: ref29 doi: 10.1111/j.0269-2813.2004.01862.x – ident: ref31 doi: 10.1002/14651858.CD006442.pub2 – ident: ref7 doi: 10.1111/apt.12942 – ident: ref10 doi: 10.1111/j.1440-1746.2011.06635.x – ident: ref6 doi: 10.1053/j.gastro.2005.09.071 |
SSID | ssj0012943 |
Score | 2.1508813 |
Snippet | Aim: Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues... Sociocultural factors are important because their different effects on the features of irritable bowel syndrome (IBS) between countries will provide clues... |
SourceID | proquest pubmed crossref karger |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 99 |
SubjectTerms | Asia - ethnology China - ethnology Cohort Studies Consensus Report Cross-Cultural Comparison Gastroenterology - methods Humans Indonesia Irritable Bowel Syndrome - diagnosis Irritable Bowel Syndrome - therapy Japan - ethnology Philippines - ethnology Practice Patterns, Physicians' - statistics & numerical data Republic of Korea - ethnology Singapore - ethnology Surveys and Questionnaires |
Title | Survey of Clinical Practice for Irritable Bowel Syndrome in East Asian Countries |
URI | https://karger.com/doi/10.1159/000369078 https://www.ncbi.nlm.nih.gov/pubmed/25632923 https://www.proquest.com/docview/1652465749 https://www.proquest.com/docview/1652448093 |
Volume | 91 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1ZS8QwEB68EF_E29VVooj4Umybpm2eZJUVFZTFA_at5FoQ11b3UPbfm2mzFUF9bYc8ZJLMfHN8A3AUaGQd46mntMI0Iws86WvqcUGpNQfc7yXYnHx7F189RTdd1nUBt6Erq5y-ieVDrQuFMfLTIGZhFLMk4mdv7x5OjcLsqhuhMQvzSF2Gpzrp1oDLmjJXNRdgC3JIHbOQteCnJRGLBYbpD3u08ILl14O_vc3S6lyuwLJzF0mr0u8qzJh8DdZbuYXKrxNyTMoCzjIyvgaLty5Pvg6dh_Hgw0xI0SOO-LNPOq4filg3lVwPMCgg-4acF5-mTx4ccQF5zklbDEekhc2VBDvWceLWcAOeLtuPF1eem53gKRqzkRcIGVnsoHhgpNZCW1jCdeoLqkTChFRUKxMzJhPKpQmlhXmSRSrBjG7ATGroJszlRW62gUQ9P9YqCTWPhQVzgsdKMKtQPzAmZJo14GS6g5lyxOI436KflQCD8aze7AYc1qJvFZvGb0IblRpqken35lQrmbtow-z7WDTgoP5trwjmPURuirGTiVKf0wZsVdqsl7YeHw2tk7vz_-K7sGQ9JVbFXpowNxqMzZ71RkZyvzxy-zB_3r7r3H8B3JXbyg |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VgoBLBX2xUMAgQFyiJnGcxAeEFmi1S7tVpbbS3oJfKyGWpOyDav9UfyMziROEBNx6TSwfPGPP980T4FVkqeuYzANjDYUZRRTo0PJAKs7RHMhwklFx8ugkHVwkn8divAbXbS0MpVW2b2L9UNvKkI98P0pFnKQiS-T7yx8BTY2i6Go7QqNRiyO3ukLKNn83_ITyfR3HhwfnHweBnyoQGJ6KRRApnSCqNjJy2lplEbBLm4eKG5UJpQ23xqVC6IxL7WKNBEiLxGQU64yEyx3HfW_BbTS8IZG9bNwRPDSdPksvopLnmPtORogY9uvGL0hE8z_s351vlO49-ze6ra3c4QPY8PCU9Rt9eghrrtyErX6J1Pz7ir1hdcJo7YnfhLsjH5ffgtOz5eynW7Fqwnyj0Sk79fVXDGExG87ICaGnjn2ortyUnflGCexryQ7UfMH6VMzJqEKeJnzNt-HiRk51B9bLqnSPgCWTMLUmi61MFZJHJVOjBCpQGDkXCyt68LY9wcL4RuY0T2Na1IRGyKI77B687JZeNt07_rZouxFDt6T9vtdKpfAXe178VsMevOh-45WkOIsqXbX0a5I8lLwHu400u60RYfIYQfXj_2_-HO4NzkfHxfHw5OgJ3EeUJhq_zx6sL2ZL9xSR0EI_q9WPwZeb1vdfGRwX9A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VLap6QdAWulDAIEBcok3sOIkPFdrSXXUpXa0olXoLfq2EWJKyD6r9a_y6jhMnCAm49ZqMfPCM7W9e3wC8ioxjHRNZoI12aUYeBSo0LBCSMXwORDhNXXPy2Tg5uYg_XPLLDfjV9MK4ssrmTqwualNqFyPvRQmnccLTWPSmvixicjx8d_UjcBOkXKa1GadRm8ipXV-j-7Y4HB2jrl9TOhx8fn8S-AkDgWYJXwaRVDEibC0iq4yRBsG7MFkomZYpl0ozo23CuUqZUJYqdIYUj3Xq8p4Rt5lluO4d2EydV9SBzaPBePKpzWHQpmYvcg3QlHleI8QPvYoGBt3S7I_X8O43V_w9_zfWrd684X2458Eq6dfW9QA2bLEDu_0CHfXva_KGVOWjVVx-B7bOfJZ-Fybnq_lPuybllHja0RmZ-G4sgiCZjOYuJKFmlhyV13ZGzj1tAvlakIFcLEnftXYS1y_v5n0t9uDiVvb1IXSKsrD7QOJpmBidUiMSia6kFImWHM0pjKyl3PAuvG12MNee1txN15jllXvDRd5udhdetqJXNZfH34T2ajW0Is33g0YruT_mi_y3UXbhRfsbD6jLusjClisvE2ehYF14VGuzXRrxJqMIsR__f_HnsIW2nn8cjU-fwDZCNl4HgQ6gs5yv7FOERUv1zNsfgS-3bfI393Ydjw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Survey+of+clinical+practice+for+irritable+bowel+syndrome+in+East+asian+countries&rft.jtitle=Digestion&rft.au=Fukudo%2C+Shin&rft.au=Hahm%2C+Ki-Baik&rft.au=Zhu%2C+Qi&rft.au=Sollano%2C+Jose+D&rft.date=2015&rft.eissn=1421-9867&rft.volume=91&rft.issue=1&rft.spage=99&rft_id=info:doi/10.1159%2F000369078&rft_id=info%3Apmid%2F25632923&rft.externalDocID=25632923 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-2823&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-2823&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-2823&client=summon |